KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Free Cash Flow (2017 - 2026)

Cardlytics filings provide 10 years of Free Cash Flow readings, the most recent being -$5.7 million for Q1 2026.

  • Quarterly Free Cash Flow rose 16.92% to -$5.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$4.9 million through Mar 2026, up 67.87% year-over-year, with the annual reading at -$6.0 million for FY2025, 77.36% up from the prior year.
  • Free Cash Flow hit -$5.7 million in Q1 2026 for Cardlytics, down from -$2.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $8.2 million in Q2 2023 and bottomed at -$22.0 million in Q1 2022.
  • Average Free Cash Flow over 5 years is -$5.5 million, with a median of -$5.1 million recorded in 2022.
  • The largest annual shift saw Free Cash Flow plummeted 687.47% in 2024 before it skyrocketed 2046.88% in 2025.
  • Cardlytics' Free Cash Flow stood at -$5.1 million in 2022, then skyrocketed by 144.43% to $2.3 million in 2023, then plummeted by 687.47% to -$13.3 million in 2024, then skyrocketed by 83.85% to -$2.2 million in 2025, then crashed by 163.6% to -$5.7 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Free Cash Flow are -$5.7 million (Q1 2026), -$2.2 million (Q4 2025), and $2.1 million (Q3 2025).